U.S. Expansion, Fundraising, and Exit: A Comprehensive FAQ

[LAST UPDATED: July 1, 2025]

For many high-growth UK/European and Israeli tech and life sciences companies, U.S. expansion, fundraising, and exit are key steps in the journey. The U.S. offers the promise of massive commercial opportunities and plentiful capital, but doing business, raising money, and maximizing enterprise value in an unfamiliar, highly competitive environment requires thoughtful advance planning and clinical execution.

Based on our discussions with UK/European and Israeli startups and scaleups over the past decade, below are over three dozen frequently asked U.S. expansion, fundraising and exit questions (with linked answers).

We intend to make this a living resource for the UK/European and Israeli tech and life sciences communities and will update it as appropriate. If there are key questions you would like to see addressed here, feel free to send me suggestions at daniel.glazer@wsgr.com.

U.S. Expansion

• Where can we find a brief summary of key U.S. expansion and fundraising considerations?
• Where can we find a short U.S. expansion “how-to” guide?
• When should our company consider expanding to the U.S.?
• How do we determine the optimal U.S. expansion strategy?
• What are the particular U.S. expansion considerations for B2B SaaS companies?
• What is the simplest way to expand to the U.S.?
• What are some of the most common mistakes made by companies expanding to the U.S.?
• What are the sales tax considerations associated with selling into the U.S.?
• When do we need to create a separate U.S. company?
• Why are so many companies incorporated in the U.S. State of Delaware, and what are the advantages of incorporating there?
• What are the new beneficial ownership reporting requirements for U.S. companies that come into effect in 2024?
• Where is the best place to establish U.S. operations?
• How is hiring employees different in the U.S., and what are the most common mistakes made by non-U.S. companies when hiring a US-based team?
• Where can we find a guide to hiring U.S. employees?
• How do we provide equity to U.S. employees and how does it differ from providing equity to employees in our home market?
• What does it cost to set up and scale a U.S. business?
• What are the primary legal considerations when setting up and scaling a U.S. business?
• What are the primary tax considerations when setting up and scaling a U.S. business?
• What are the primary business insurance considerations when setting up and scaling a U.S. business?
• What are the primary immigration considerations when relocating to the U.S. to set up and scale a U.S. business?
• What are the other key administrative and logistical considerations?
• What should we consider with respect to U.S. patents and trademarks?
• What role do lawyers play in scaling a U.S. business?
• How do we manage the risk of U.S. litigation?
• To what extent do we need to work with U.S. lawyers and other U.S. professional advisors?
• What are the key considerations when expanding through M&A?
• What are the unique considerations for health tech companies expanding to the U.S.?
• What are the unique considerations for fintech companies expanding to the U.S.?
• What are the key considerations when offering payment services in the U.S.?
• What U.S. government resources and UK government resources are available to assist companies with U.S. expansion?
• Where can we learn more about U.S. expansion?

U.S. Fundraising

• Should we “flip” into a U.S. (Delaware) parent company to raise money from U.S. VC investors?
• What are the UK tax implications of “flipping” into a U.S. parent company?
• Where can we find a short U.S. fundraising “how-to” guide?
• How can I construct a term sheet that contemplates a U.S. VC investor leading a financing for a UK company?
• Will U.S. VC investors invest in early-stage non-U.S. based businesses?
• When should our company look to raise capital from U.S. VC investors?
• How do venture capital deal terms differ between the U.S. and UK/Europe?
• What are the key differences between U.S. and UK/European VC investors?
• How does raising capital from U.S. VC investors differ from raising capital outside the U.S.?
• What are the growth rate and exit expectations of U.S. VC investors?
• How do we meet U.S. VC investors?
• How do we pitch to U.S. VC investors as a non-U.S. team?
• What should we look out for in term sheets from U.S. VC investors?
• How do we structure a financing round with a cross-border investor group?
• How do U.S. financing transactions differ from UK/European financing transactions?
• How do we use a Y Combinator-style SAFE as a UK company raising from U.S. investors?
• How do the U.S. and UK approaches to warranties and disclosures differ in financing transactions?
• How do the U.S. and UK approaches to legal opinions differ in financing transactions?
• How do board expectations differ between the UK and U.S.?
• What are the primary tax considerations when U.S. investors invest in non-U.S. companies?
• What is the typical cost of a U.S.-led financing transaction?
• Where can we learn more about U.S. fundraising?

U.S. Exit

• What should non-U.S. companies consider when preparing for a U.S. exit?
• What are the particular considerations for an acquisition by a U.S. acquirer?
• What are the particular considerations for SaaS companies being acquired by a U.S. acquirer?
• What are the particular considerations for a U.S. IPO?
• What are the legal and regulatory considerations associated with being a U.S.-listed company?

Daniel Glazer is the founding and managing partner of Wilson Sonsini’s London office and U.S. Expansion Group. He can be reached at daniel.glazer@wsgr.com and through Linkedin. The linked resources above do not constitute legal advice and should not be relied on for business or legal decisions.